GFM
MEDP icon

GF Fund Management’s Medpace MEDP Stock Holding History

GF Fund Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$320K Sell
604
-28
-4% -$12.9K ﹤0.01% 235
2026
Q1 		$303K Buy
632
+80
+14% +$41K 0.01% 252
2025
Q4 		$310K Sell
552
-52
-9% -$29.5K 0.01% 252
2025
Q3 		$311K Sell
604
-192
-24% -$83.8K 0.01% 252
2025
Q2 		$250K Hold
796
– – 0.01% 304
2025
Q1 		$243K Buy
796
+143
+22% +$48.1K 0.01% 306
2024
Q4 		$217K Buy
+653
New +$221K ﹤0.01% 283

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

GF Fund Management's MEDP Position: Q2 2026 in Review

GF Fund Management reduced its Medpace (MEDP) stake by 4.4% in Q2 2026, selling an estimated $12.9K and leaving 604 shares worth $320K. The position accounts for ﹤0.01% of the portfolio, ranked #235.

GF Fund Management first reported a position in MEDP in Q4 2024 and has held it in 7 quarters since. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • GF Fund Management held 604 shares of Medpace worth $320K as of Q2 2026.
  • GF Fund Management sold 28 Medpace shares in Q2 2026, an estimated $12.9K.
  • Medpace made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #235 holding.
  • GF Fund Management first reported a position in Medpace in Q4 2024 and has held it in 7 quarters since.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.